Bruker prelim Q4 2025 revenue $965-970M; FY26 outlook flat to low-single-digit organic growth

BRUKER CORP

Q4 2025 preliminary revenue $965-970M; scientific instruments book-to-bill above 1.0.
FY 2026 outlook: organic revenue growth flat to up low-single digits vs. 2025.
Non-GAAP organic operating margins expected to expand 250-300 bps in FY26.
Non-GAAP EPS for FY26 expected to grow double-digits compared to FY25.
Forward-looking statements subject to final audit and adjustments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.